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Background/aim: This study aimed to evaluate the regression pattern with the distal intramural spread (DIS) of rectum cancer after
preoperative chemoradiation.
Materials and methods: Specimens from 56 patients who underwent radical resection after preoperative chemoradiation for rectal
cancer were examined. The regression pattern (total, fragmented) of the tumor was recorded. DIS status was evaluated by creating
sections 0.2 to 0.3 cm thick.
Results: A single macroscopic residual area was detected in all specimens. In 10 patients (17.8 %), pathologically complete responses
were identified, and DIS was detected in 33 patients (58.9%). The average DIS distance was 0.56 ± 0.3 cm (range 0.2 – 1.8 cm); the spread
was < 1 cm in 87.9% of the patients (29/33). The overall survival rates for 5 and 7 years were 76.8% and 73.2%, respectively. The survival
rates between patients with and without DIS were not statistically different (94.6 ± 5.5 vs. 75.1 ± 10.2 months, respectively). In all of the
patients, tumor regression pattern was total shrinkage of the tumor.
Conclusion: A sufficient distal resection margin for rectal cancer after preoperative chemoradiation is 1 cm in the vast majority of cases.
However, DIS may exceed 1 cm in a small proportion of patients.
Key words: Rectum cancer, neoadjuvant therapy, resection margin

1. Introduction
Neoadjuvant treatment in the form of chemoradiation
has been widely used for rectal cancer, and preoperative
chemoradiation is currently regarded as the standard
approach for patients with locally advanced or lymph
node involvement rectal cancer [1–3]. Preoperative
chemoradiation may lead to marked tumor regression in
a considerable proportion of patients. Moreover, in some
patients, complete responses may be seen [1–3]. However,
the microscopic extension of the tumor after regression of
the gross tumor has not been sufficiently demonstrated.
A 2-cm distal surgical margin is generally accepted in
rectal cancer patients, although this widely depends on
information obtained from rectal cancer patients without
neoadjuvant chemoradiotherapy (NCRT) [4,5]. However,
more recently, a distal resection margin ≤ 1 cm has also
been found to be acceptable in patients receiving NCRT

[6,7]. This issue has been examined in a limited number
of studies. The extent of microscopic intramural spread
beyond the gross margin of the tumor should be thoroughly
investigated to obtain a clear distal margin in patients
receiving NCRT. There is, however, limited information
about the pattern of regression in the literature. Both in
regression with total shrinkage of the tumor [1] and with a
fragmented pattern, leaving residual clusters of cancer cells
distant from the gross tumor [8] has been suggested, in only
a few studies and with relatively low numbers of patients.
This study aims to evaluate the extent of distal
microscopic spread and the regression pattern after NCRT
in rectal cancer patients.
2. Materials and methods
The study was approved by the Institutional Review
Board. 2011 and 2013, the specimens of rectal cancer
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patients who underwent radical surgery after NCRT
were prospectively evaluated. The patients were evaluated
by physical examination, routine laboratory tests,
colonoscopy, colonoscopic biopsy, and computerized
tomography. The distance of the distal tumor margin from
anal verge was determined preoperatively by rectoscopic
exam. Magnetic resonance imaging, endosonography, and
positron emission tomography (PET) were performed
when necessary. The indications for NCRT were clinical
T3 and T4 tumors and/or suspected lymph node
metastasis. All patients included in the study received
NCRT. Radiotherapy (4500–5040 cGy) was administered
in combination with 5-fluorouracil in all patients. The
patients underwent resection with mesorectal excision
approximately for 6 to 10 weeks after NCRT. Since some
of the patients were evaluated in other centers before
neoadjuvant treatment, some data about pretreatment
could not be obtained. Patients with distant metastasis
were excluded. Age, sex, localization of the tumor, time of
surgery after NCRT, distance to surgical margin, number
of lymph nodes, lymphatic invasion, T stage, N status,
type of operation, distal intramural spread (DIS), status of
distal and circumferential surgical margins, and long-term
survival were recorded.
Histopathologic evaluation was performed by a
single pathologist. The entire distance between the distal
margin of the tumor and the distal surgical margin was
totally mapped, the whole rectal wall was evaluated using
0.2–0.3 cm thick macroscopic sections, and the extent of
distal spread and pattern of regression were recorded. Size,
localization, distance to the distal surgical margin, status
of circumferential resection (radial) margin (CRM), and
tumor regression grade (TRG) were also recorded. Staging
was performed according to the 7th AJCC classification
[9]. TRG was evaluated and graded according to a modified
version of Ryan’s regression grading system [9,10] (see
Table 1).
A macroscopic margin was defined as the distance
between the distal edge of the macroscopic tumor (lesion
or scar tissue) and the distal surgical margin. A microscopic
margin was defined as the distance between the most
distally located tumor cells and the distal surgical margin.

DIS was defined as the distance between the edge of the
macroscopic tumor (lesion or scar) and the most distally
located tumor cells. Pathological complete response was
defined as the absence of tumor cells in the specimen.
Follow-up information was obtained from hospital
records and telephone interviews.
2.1. Statistical analyses
Statistical analyses were performed using SPSS 20.0
(IBM Corp., Armonk, NY, USA). Numerical variables
are expressed as mean ± standard deviation (SD), and
categorical variables are given as frequencies. Survival
analyses were performed by Kaplan–Meier and Log-rank
tests. In the test of two-sided hypotheses, a p-value < 0.05
was considered as statistically significant.
3. Results
Of the 56 patients included in the study, 47 underwent
low anterior resection (LAR), and 9 patients underwent
abdominoperineal resection (APR). None of the
patients had distant metastasis at the time of surgery.
The clinicopathological characteristics of the patients
are shown in Table 2. According to the preoperative
evaluation, the mean distance of the tumor from the anal
verge was 6.46 ± 2.6 (2–12) cm. Ten patients (17.9%)
showed pathological complete response according to the
pathological evaluation of the resected specimen. In all
the patients, including those with complete response, an
inflammatory and fibrous residual lesion was observed.
3.1. Distal intramural spread status
The distal surgical margin was free of tumor cells in all
patients. DIS was less than 1 cm, except in four patients:
two had 1 cm DIS, the other two had 1.2 and 1.8 cm DIS.
Among patients without a complete response (46 patients),
DIS was not observed in 13 patients (28.3%). In 22 patients
(47.8%) ≤ 5 mm, DIS was seen, and the remaining seven
patients showed 6–9 mm DIS.
3.2. Circumferential radial margin status
The mean distance to CRM was 0.91 ± 0.76 cm when
patients with complete responses were excluded. CRM was
positive in three patients. In two patients, the distance to
CRM was ≤ 1 mm.

Table 1. Modified Ryan’s grading system for tumor regression grading in rectal cancer treated
with preoperative therapy [9,10].
Description

Tumor Regression Grade (TRG)

No viable cancer cells (complete response)

0

Single cells or small groups of cancer cells

1

Residual cancer with fibrosis

2

Extensive residual cancer or minimal response

3
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Table 2. The clinicopathological characteristics of the patients.
Characteristic

n: 56

Age (Year)

56.96 ± 12.03

Sex
Male

18 (%32.1)

Female

38 (%67.9)

BMI (kg/m )
2

26.80 ± 4.42

Co-morbidity
Yes

26 (%46.4)

No

30 (%53.6)

ASA Score
I

21 (%37.5)

II

30 (%53.6)

III
Tumor Localization (cm)

5 (%8.9)
6.46 ± 2.6 (range 2-12)

Clinical Stage (c Stage)
c T3 N0

17(%30.4)

c T3 N1

36(%64.3)

c T4 N0

1 (%1.8)

c T4 N1

2 (%3.6)

Interval Time (day)

58.7 ± 21.5 (range 24–123)

Operation Type
Low Anterior Resection (LAR)

47(%83.9)

Abdominoperineal Resection (APR)

9 (%16.1)

3.3. Lymph node status:
The mean number of harvested lymph nodes was
26.83 ± 8.91 (range 12–46). Of the 56 patients, 17 had
metastatic lymph nodes and the remaining 39 were N0.
All histopathological outcomes are summarized in Table 3.
3.4. Overall survival:
The mean follow-up was 79.4 ± 26.6 (range 10–114)
months, and the overall survival was 93.8 ± 4.5 (95%
confidence interval 85–102.5) months. The five- and
seven-year survival rates were 76.8% and 73.2%,
respectively (Figure 1). Sixteen deaths occurred during
follow-up. Of these, nine (56.2%) had DIS, while seven
did not. Survival was not statistically different between
patients with and without DIS (Figure 2). In patients
with CRM distance ≤ 1 mm, mean survival was 46.8 ±
13.7 (95% confidence interval 19.8 –73.6) and 100.2
± 4.0 (95% confidence interval 92.3–108) months in
patients with CRM distance > 1mm. The difference was
statistically significant (p < 0.001) (Figure 3). The mean
survival by lymph node status (N+, N0) was 72.9 ± 9.7
(95% confidence interval 53.9–91.9) months and 101.1
± 3.9 (95% confidence interval 93.3–108.8) months,
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respectively. The difference was statistically significant (p
< 0.05) (Figure 4).
4. Discussion
In addition to the histopathological evaluation of the distal
surgical margin, we made a detailed study of the entire
rectal wall, from the macroscopic tumor (or macroscopic
residual lesion) to the distal surgical margin after NCRT.
This area was mapped with 0.2–0.3 cm thick macroscopic
sections, smaller than those used in previous studies, to
thoroughly evaluate the entire rectal wall distal to the
tumor. Although there are studies concerning the distal
spread of rectal cancer, there has, to date, been a lack of
studies performing such a detailed histopathological
evaluation on distal spread and regression patterns.
However, in 2005, Mezhir et al. [1] evaluated DIS after
preoperative therapy on 20 patients. The pathological
evaluation of the distal spread was performed using 0.5
cm cuts. The extent of the spread was 1 cm in five patients
(25%); in only one patient was the distal spread more than
1 cm, although the specific spread was 2.5 cm. The authors
concluded that, in patients having received preoperative
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Table 3. The histopathological outcomes of the patients.
Histopathological Variables

n: 56

Tumor Size (cm)

1.98 ± 0.85

Distal Surgical Margin (Macroscopic) (cm)

3.15 ± 1.58 (range 0.5–7.2)

Distal Surgical Margin (Microscopic) (cm)

2.79 ± 1.54 (range 0.15–6.5)

Circumferential Resection Margin (cm)

0.91 ± 0.76

Circumferential Resection Margin Status
Negative (>1mm)

51 (%91.1)

Positive (≤ 1 mm)

5 (%8.9)

Distal Intramural Spread* (cm)

0.56±0.3 (range 0.2-1.8)

Pathological T Stage
p T0

10 (%17.8)

p T1

3 (%5.4)

p T2

12 (%21.4)

p T3

30 (%53.6)

p T4b

1 (%1.8)

Harvested Lymph Node

26.83 ± 8.91(range 12–46)

Positive Lymph Node

1.25 ± 2.70 (range 0–11)

Tumor Regression Grade (TRG)
TRG 0

10 (%17.9)

TRG 1

16 (%28.6)

TRG 2

20 (%35.7)

TRG 3

9 (%16.1)

Unknown

1 (%1.8)

Perineural Invasion
Yes

19(%33.9)

No

37(%66.1)

Lymphovascular Invasion
Yes

22(%39.3)

No

31(%55.4)

Uncertain

3(%5.4)

Tumor Stage
Stage 0

10(%17.9)

Stage 1

13(%23.2)

Stage 2a

14(%25)

Stage 3a

1(%1,8)

Stage 3b

15(%26.8)

Stage 3c

3(%5.4)

* n: 33

therapy, a 2 cm distal margin was adequate, although
they also stated that intramural spread rarely exceeded
1 cm from the gross margin [1]. Our study included
56 patients on whom histopathological evaluation was

conducted using 0.2– 0.3 cm cuts macroscopically. The
distance from the gross lesion margin and the surgical
margin was evaluated similarly. In our study group, ≥ 1
cm DIS was observed only in four patients (7.1%). One
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Overall Survival
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Figure 1. Kaplan–Meier curves of overall survival in the cohort.
Overall Survival by DIS Status
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Figure 2. Kaplan-Meier curves of overall survival by DIS status in the cohort (p > 0.05).

patient, with a pT3N2, poorly differentiated tumor with
perineural and lymphovascular invasion, showed 1.8 cm
DIS. Extensive DIS has been shown to be associated with
poor histopathological features, advanced disease, and
poor survival rates in non-irradiated rectal cancers [11,12],
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consistent with our findings. Of our patients, one with 1.2
cm DIS and two with 1 cm DIS had metastatic lymph nodes
as well as perineural and/or lymphovascular invasion.
However, the limited number of our patients did not allow
us to determine possible risk factors for extensive DIS.
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Overall Survival by CRM Status
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Figure 3. Kaplan–Meier curves of overall survival by CRM status in the cohort (p < 0.001).
Overall Survival by Lymph Node Status
Lymph Node
Status
Negative
Positive
Negative-censored
Positive-censored
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Figure 4. Kaplan–Meier curves of overall survival by lymph node status in the cohort (p < 0.05).

Complete response was seen in 10 patients in our study.
Among the remaining 46 patients, 35 (76.1%) showed
no DIS or ≤ 5mm DIS, while the remaining 7 showed 6
to 9 mm DIS. Approximately 93% had < 1 cm DIS. The
relatively high rate of DIS ≤ 5mm may be due to thinner

macroscopic sections when compared to those used in
other studies.
Our landmark in evaluating distal spread was the
distal edge of the tumor after NCRT. We were, thus, able
to see possible residual tumor foci if the regression was
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fragmented. However, we did not observe any fragmented
tumor regression patterns. One of our most important
findings was that tumor regression patterns showed a
total shrinkage of the tumor in all patients. This finding
should encourage surgeons to accept the distal edge of
the postradiation lesion as the landmark for the distal
resection margin, which could lead to higher rates of
sphincter preservation. Hayden et al. [13] identified
microscopic tumor cells outside a visible ulcer in 27
patients (49.1%) who received NCRT. The mean distal
scatter was 1 cm, with a maximum of 3 cm in their study,
and the authors concluded that the distal margin should
not be used to guide the resection margin and a 2 cm
margin might not be adequate in those patients. They
suggested decisions regarding operations should be based
on the preradiation features of the tumors. Discontinuous
spread has also been observed in some studies [8,14].
These findings are inconsistent with our results. Although
we evaluated the entire distal rectal wall using relatively
thinner macroscopic sections in a considerable number
of patients, we did not observe any tumor cells scattered
outside the tumor. Our results are, though, consistent
with more recent studies. Mezhir et al. [15] stated that
DIS rarely exceeded 1 cm, although they observed DIS in
only 10 of 103 patients, which was lower than our study.
They concluded that in patients who received NCRT, local
control could be achieved with a distal resection margin of
1 cm [15]. Due to improvements in anastomotic devices
and surgical techniques, sphincter preservation in rectal
cancer patients has gained more importance. Following
recent studies, the 2 cm distal margin tenet has been
modified to 1 cm in patients receiving NCRT [6,7,16].
In their systematic review, Pahlman et al. [16] suggested
that, for patients receiving preoperative or postoperative
radiotherapy, even a ≤ 1 cm distal resection margin was
sufficiently disassociated with an increased risk of local
recurrence. They also added that their findings supported
performing resection with a distal margin shorter than
1 cm when preoperative radiotherapy was selectively
used. Similarly, Bujko et al. [6] showed that a distal
margin of less than 1 cm was not associated with higher

local recurrence and survival in highly selected patients.
They also suggested that sphincter preservation might be
possible with a distal margin of less than 1 cm in selected
patients. However, in none of these studies, the selection
criteria were clearly defined.
It has been previously reported that presence of DIS
increases the risk of distant metastasis and negatively
affects survival [11,17]. This finding is usually the outcome
of patients with locally advanced tumors who did not
receive preoperative treatment. No relationship has been
found between DIS and metastasis or survival in patients
who underwent neoadjuvant CRT [1]. In the present study,
we found that DIS status does not affect overall survival.
Although none of the patients had a positive distal
margin, CRM was positive in three patients, and the
distance to CRM was ≤ 1mm in two patients. The survival
rates of these five patients were significantly worse than for
CRM negative patients.
In patients with mid- and upper-rectum cancers, an
adequate distal surgical margin can be easily achieved,
and sphincter preservation is possible with an even
longer distal margin. For low-lying rectal cancers, a total
mesorectal excision is performed, with distal spread being
the main concern. Our findings in this study are especially
important for this group of patients for whom quality of
life is an important issue. The safest approach is a 2 cm
distal margin. However, a 1 cm distal margin would seem
to be adequate in the vast majority of patients. Identifying
patients who are likely to have more than 1 cm DIS requires
further studies to avoid unnecessary abdominoperineal
resections.
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